Yoshida K - Search Results

1

Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models.

Bruno R, Chanu P, Kågedal M, Mercier F, Yoshida K, Guedj J, Li C, Beyer U, Jin JY. Bruno R, et al. Among authors: yoshida k. Br J Cancer. 2023 Oct;129(9):1383-1388. doi: 10.1038/s41416-023-02190-5. Epub 2023 Feb 10. Br J Cancer. 2023. PMID: 36765177 Free PMC article. Review.

2

Impact of physiologically based pharmacokinetic models on regulatory reviews and product labels: Frequent utilization in the field of oncology.

Yoshida K, Budha N, Jin JY. Yoshida K, et al. Clin Pharmacol Ther. 2017 May;101(5):597-602. doi: 10.1002/cpt.622. Epub 2017 Mar 15. Clin Pharmacol Ther. 2017. PMID: 28074611 Free PMC article. Review.

3

Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease.

Yoshida K, Moein A, Bittner T, Ostrowitzki S, Lin H, Honigberg L, Jin JY, Quartino A. Yoshida K, et al. Alzheimers Res Ther. 2020 Jan 22;12(1):16. doi: 10.1186/s13195-020-0580-2. Alzheimers Res Ther. 2020. PMID: 31969177 Free PMC article. Clinical Trial.

4

Physiologically-Based Pharmacokinetic Model-Informed Drug Development for Fenebrutinib: Understanding Complex Drug-Drug Interactions.

Chen Y, Ma F, Jones NS, Yoshida K, Chiang PC, Durk MR, Wright MR, Jin JY, Chinn LW. Chen Y, et al. Among authors: yoshida k. CPT Pharmacometrics Syst Pharmacol. 2020 Jun;9(6):332-341. doi: 10.1002/psp4.12515. Epub 2020 May 29. CPT Pharmacometrics Syst Pharmacol. 2020. PMID: 32383787 Free PMC article.

5

Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition-overall survival modeling framework.

Chan P, Marchand M, Yoshida K, Vadhavkar S, Wang N, Lin A, Wu B, Ballinger M, Sternheim N, Jin JY, Bruno R. Chan P, et al. Among authors: yoshida k. CPT Pharmacometrics Syst Pharmacol. 2021 Oct;10(10):1171-1182. doi: 10.1002/psp4.12686. Epub 2021 Aug 4. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34270868 Free PMC article.

6

Population Pharmacokinetics of Ipatasertib and Its Metabolite in Cancer Patients.

Yoshida K, Wilkins J, Winkler J, Wade JR, Kotani N, Wang N, Sane R, Chanu P. Yoshida K, et al. J Clin Pharmacol. 2021 Dec;61(12):1579-1591. doi: 10.1002/jcph.1942. Epub 2021 Aug 11. J Clin Pharmacol. 2021. PMID: 34273118 Clinical Trial.

7

Assessment of cytochrome P450 3A4-mediated drug-drug interactions for ipatasertib using a fit-for-purpose physiologically based pharmacokinetic model.

Jing J, Chen Y, Musib L, Jin JY, Cheung KWK, Yoshida K, Sane R. Jing J, et al. Among authors: yoshida k. Cancer Chemother Pharmacol. 2022 May;89(5):707-720. doi: 10.1007/s00280-022-04434-2. Epub 2022 Apr 15. Cancer Chemother Pharmacol. 2022. PMID: 35428895 Free PMC article.

8

Tumor Growth Inhibition-Overall Survival (TGI-OS) Model for Subgroup Analysis Based on Post-Randomization Factors: Application for Anti-drug Antibody (ADA) Subgroup Analysis of Atezolizumab in the IMpower150 Study.

Yoshida K, Chan P, Marchand M, Zhang R, Wu B, Ballinger M, Sternheim N, Jin JY, Bruno R. Yoshida K, et al. AAPS J. 2022 Apr 28;24(3):58. doi: 10.1208/s12248-022-00710-4. AAPS J. 2022. PMID: 35484442

9

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150.

Bruno R, Marchand M, Yoshida K, Chan P, Li H, Zou W, Mercier F, Chanu P, Wu B, Lee A, Li C, Jin JY, Maitland ML, Reck M, Socinski MA. Bruno R, et al. Among authors: yoshida k. Clin Cancer Res. 2023 Mar 14;29(6):1047-1055. doi: 10.1158/1078-0432.CCR-22-2323. Clin Cancer Res. 2023. PMID: 36595566 Free PMC article. Clinical Trial.

10

Concentration QTc analysis of giredestrant: Overcoming QT/heart rate confounding in the presence of drug-induced heart rate changes.

Brooks L, Dolton M, Langenhorst J, Yoshida K, Lien YTK, Malhi V, Li C, Perez-Moreno P, Bond J, Chen YC, Yu J. Brooks L, et al. Among authors: yoshida k. Clin Transl Sci. 2023 May;16(5):823-834. doi: 10.1111/cts.13491. Epub 2023 Feb 22. Clin Transl Sci. 2023. PMID: 36772881 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,577 results

Search Page